Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: chirodoc who wrote (5732)	11/15/2000 11:04:37 AM
From: peter michaelson	Read Replies (3) \| Respond to of 6039

The ostrich investment philosophy?

To: chirodoc who wrote (5732)	11/15/2000 10:32:14 PM
From: chirodoc	Read Replies (1) \| Respond to of 6039

********HOW ACCURATE IS CTI?****** ACCURACY (SENSITIVITY) OF 96%!! Paper Title: Computerized Thermal Breast Imaging Revisited: An Adjunctive Tool to Mammography Authors: Parisky YR, Skinner KA, Cothren R, DeWittey RL, Birbeck JS, Conti PS, Rich JK, Dougherty WR Date of Presentation: 8:30 to 10:00 Oct. 31 SAT Room: Rm207/208 Abstract: Physical examination and mammography are the primary methods for the detection of breast cancer, but lead to a high rate of benign biopsies. A digital thermal imaging system was developed as an adjunct to mammography to aid in the differentiation of benign from malignant lesions. Patients scheduled for biopsy were enrolled after informed consent. Prior to biopsy, digital thermal images were acquired of each breast during a 3.5 minute procedure. A probability of malignancy was assigned to each pixel, based on comparative statistical analysis of the thermal response features from the test subjects with data derived from lesions of known pathology. One hundred and seventeen female patients (125 suspicious lesions) were included, with a 24% true malignancy rate. Receiver Operating Characteristics (ROC) curves (Sensitivity vs. 1-Specificity) were generated based on various features of the cooling model. Based on the ROC curve analysis, 36/95 benign biopsies (38%) could have been avoided using this technology, while maintaining a sensitivity of 96%. Digital thermal imaging appears to be a valuable adjunct to mammography in the management of breast lesions, potentially decreasing the number of benign biopsies. Multi-institutional FDA clinical trials are currently underway.